University of Miami (FL) — Publications
University of Miami (FL)
Publications
University of Miami (FL)University of Miami Miller School of MedicineMayo Clinic ArizonaStanford University
Complication-Free Survival in a Real-World Cohort of PBC Patients: Deep Versus Adequate ALP Response to UDCA
University of Miami (FL)National University of Singapore / National University HospitalUNCVCUMercy Medical Center / University of Maryland
A Pragmatic Clinical Prognostic Classification Suitable for Universal Application Stratifies Patients with NAFLD by Risk of Mortality and Both Hepatic and Extrahepatic Outcomes
University of Miami (FL)Mayo Clinic PhoenixStanford University Medical CenterBanner-University of Arizona
Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) overlap syndrome: Characteristics and response to obeticholic acid (OCA) in TARGET-PBC, a diverse, large United States (US) real-world cohort (DDW 2019)
9
Total Publications
9
Poster Presentation
2025 · Poster Presentation · University of Miami (FL) · Hepatology
Changes in The Fibrosis-4 (FIB-4) Score Accurately Reflects The Disease Trajectory of Metabolic Dysfunction Associated Steatotic Liver Disease
Read more →2024 · Poster Presentation · University of Miami (FL) · Hepatology
Complication-Free Survival in a Real-World Cohort of PBC Patients: Deep Versus Adequate ALP Response to UDCA
Read more →2020 · Poster Presentation · University of Miami (FL) · Hepatology
A Pragmatic Clinical Prognostic Classification Suitable for Universal Application Stratifies Patients with NAFLD by Risk of Mortality and Both Hepatic and Extrahepatic Outcomes
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
Lean NAFLD patients have lower prevalence of cardiovascular, metabolic and severe liver disease compared to overweight or obese patients with NAFLD
Read more →2019 · Poster Presentation · University of Miami (FL) · Hepatology
Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) overlap syndrome: Characteristics and response to obeticholic acid (OCA) in TARGET-PBC, a diverse, large United States (US) real-world cohort (DDW 2019)
Read more →2019 · Poster Presentation · University of Miami (FL) · Hepatology
Change in Lipids: Characteristics and Response to Obeticholic Acid (OCA) in TARGET-PBC, a Diverse, Large United States (US) Real-world Cohort (DDW 2019)
Read more →2018 · Poster Presentation · University of Texas Southwestern · Hepatology
Patient-Reported Indicators of Health and Symptoms in US Patients with Primary Biliary Cholangitis (PBC)
Read more →2018 · Poster Presentation · Stanford · Hepatology
Primary Biliary Cholangitis (PBC) in the U.S.: Real World Effectiveness of Obeticholic Acid in TARGET-PBC (DDW)
Read more →2018 · Poster Presentation · Stanford · Hepatology